Difference in Efficacy of Antihypertensive Given in Morning vs Evening
DOI:
https://doi.org/10.70749/ijbr.v3i6.1600Keywords:
Difference, Efficacy, Antihypertensive, Morning, EveningAbstract
Background: The long-term antihypertensive drugs of 24-hour stable blood pressure can control the large fluctuation of morning blood pressure and reduce the rise of morning peak blood pressure caused by failure to take medicine on time or missing. Objective: To determine the difference in efficacy of antihypertensive given in morning vs evening, at a tertiary care hospital, Karachi. Material and Methods: A randomized controlled trial was conducted at Liaquat National Hospital & Medical College, Karachi from March 2024 to Sep 2024. 200 hypertensive patients were randomly assigned to Morning (Group-A) or Evening/Night (Group-B) medication groups. For diagnosing and evaluating hypertension, ABPM was performed using validated devices that recorded systolic and diastolic blood pressure at regular intervals over 24 hours. Data were analyzed using SPSS, applying appropriate statistical tests (parametric and non-parametric) to compare outcomes. A p-value ≤0.05 was considered statistically significant. Results: Group-A had 62% males and 38% females, while Group-B had 66% males and 34% females. Hypertension duration was significantly longer in Group-B (16.32±8.10 months vs. 10.64±5.82 months, p<0.001). Blood pressure reductions favored evening administration, with post-systolic and post-diastolic blood pressures decreasing significantly in Group-B (135.40±9.00 mmHg, 73.81±6.78 mmHg) compared to Group-A (142.41±12.93 mmHg, 82.39±6.19 mmHg, p<0.001). The main outcome revealed superior efficacy in the evening group, where 87% reported effectiveness compared to 53% in the morning group. Conclusion: Our study results demonstrate that evening administration of antihypertensive medications significantly improves efficacy compared to morning dosing, with greater reductions in systolic and diastolic blood pressures and higher effectiveness rate.
Downloads
References
Lee EK, Wang S, Ng WL, Ramdzan SN, Tse E, Chan L, et al. Evening dosing versus morning dosing of antihypertensive medications for nocturnal hypertension: a systematic review and meta-analysis of 107 randomized controlled trials. J Hypertens. 2024 Oct;42(10):1653-64.
https://doi.org/10.1097/hjh.0000000000003783
Ojha S, Tanwani H, Tiwari A, Dubey S. A Comparative Study of Morning & Evening Doses of Telmisartan in Patients of Hypertension in A Tertiary Care Hospital; A Prospective Observational Study. Int J Pharm Sci Rev Res. 2024 October;84(10):86-92.
Kjeldsen SE. Hypertension and cardiovascular risk: general aspects. Pharmacol Res. 2018;129:95–9.
https://doi.org/10.1016/j.phrs.2017.11.003
Zhao J, Zeng Y, Weng J, Zhang J, Yao T, Yuan M, et al. Evening versus morning administration of drug therapy for hypertension: A meta-analysis of randomized controlled trials. Eur J Integrat Med. 2022;50:102111.
https://doi.org/10.1016/j.eujim.2022.102111
Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison HC, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/ AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol. 2018;71:2199–269
Yusuf S, Joseph P, Rangarajan S. Modifiable risk factors, cardiovascular disease, and mortality in 155722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2020;395:795–808
https://doi.org/10.1016/s0140-6736(19)32008-2
Zhao P, Xu P, Wan CM, Wang ZR. Evening versus morning dosing regimen drug therapy for hypertension, Cochrane Database. Syst Rev. 2011;10:Cd004184,
Hermida RC, Smolensky MH, Balan H, Castriotta RG, Crespo JJ, Dagan Y, et al. Guidelines for the design and conduct of human clinical trials on ingestion-time differences - chronopharmacology and chronotherapy - of hypertension medications. Chronobiol Int. 2021;38:1–26.
https://doi.org/10.1080/07420528.2020.1850468
Staplin N, de la Sierra A, Ruilope LM, Emberson JR, Vinyoles E, Gorostidi M, et al. Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59124 patients. Lancet. 2023;401:2041–50.
Ishikawa J, Shimizu M, Edison ES, Yano Y, Hoshide S, Eguchi K, et al. Assessment of the reductions in night-time blood pressure and dipping induced by antihypertensive medication using a home blood pressure monitor. J Hypertens. 2014;32:82–9.
https://doi.org/10.1097/hjh.0b013e328365c8a8
Hermida RC, Ayala DE, Smolensky MH, Fern´andez JR, Moj´on A, Portaluppi F. Chronotheray with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks. Hypertens Res. 2016;39:277–92.
https://doi.org/10.1038/hr.2015.142
Maqsood MH, Messerli FH, Skolnick AH, Newman JD, Berger JS, Bangalore S. Timing of Antihypertensive Drug Therapy: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Hyperten. 2023;80:1544–54.
Mackenzie IS, Rogers A, Poulter NR, Williams B, Brown MJ, Webb DJ, et al. Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomized, openlabel, blinded-endpoint clinical trial. Lancet. 2022;400:1417–25.
https://doi.org/10.1016/s0140-6736(22)01786-x
Hermida RC, Crespo JJ, Domínguez-Sardiña M, Otero A, Moyá A, Ríos MT, et al. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial. Eur Heart J. 2020;41:4565–76
ESC Press Office. Evening dosing of blood pressure medication not better than morning dosing: TIME trial presented in a Hot Line Session today at ESC Congress 2022. European Society of Cardiology; 2022. https://www.escardio.org/The-ESC/Press-Office/Press-releases/Evening-dosing-ofblood-pressure-medication-not-better-than-morning-dosing
Stergiou G, Brunström M, MacDonald T, Kyriakoulis KG, Bursztyn M, Khan N, et al. Bedtime dosing of antihypertensive medications: systematic review and consensus statement: International Society of Hypertension position paper endorsed by World Hypertension League and European Society of Hypertension. J Hypertens. 2022;40:1847–58.
https://doi.org/10.1097/hjh.0000000000003240
Kario K. Perfect 24-h management of hypertension: clinical relevanceand perspectives. J Hum Hypertens. 2017;31:231–43
https://doi.org/10.1038/jhh.2016.65
Zhang P, Jin MY, Song XY, Wang Z, Jiang YH, Yang CH, et al. Comparison of the antihypertensive efficacy of morning and bedtime dosing on reducing morning blood pressure surge: a protocol for systemic review and meta-analysis. Me. 2021 Feb;100(5).
https://doi.org/10.1097/md.0000000000024127
Thomas S, Booth J, Jaeger B. Association of sleep characteristics with nocturnal hypertension and nondipping blood pressure in the CARDIA study. J Am Heart Assoc. 2020;9:e015062.
https://doi.org/10.1161/jaha.119.015062
Häusler N, Marques-Vidal P, Haba-Rubio J. Association between actigraphy-based sleep duration variability and cardiovascular risk factors – results of a population-based study. Sleep Med. 2020;66:286–90.
https://doi.org/10.1016/j.sleep.2019.02.008
Booth J, Jaeger B, Huang L. Morning blood pressure surge and cardiovascular disease events and all cause mortality in Blacks: the Jackson Heart study. Hypertension. 2020;75:835–43.
https://doi.org/10.1161/hypertensionaha.119.14233
Hermida RC, Ayala DE, Fernandez JR, Calvo C. Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension. Hypertension. 2007 Oct 1;50(4):715-22.
https://doi.org/10.1161/hypertensionaha.107.094235
Zhang P, Jin MY, Song XY, Wang Z, Jiang YH, Yang CH. Comparison of the antihypertensive efficacy of morning and bedtime dosing on reducing morning blood pressure surge: A protocol for systemic review and meta analysis. Medi. 2021;100:5(e24127).
https://doi.org/10.1097/md.0000000000024127
Bowman M, Buysse D, Foust J. Disturbed sleep as a mechanism of race differences in nocturnal blood pressure non-dipping. Curr Hypertens Rep. 2019;21:51.
https://doi.org/10.1007/s11906-019-0954-7
Thomas S, Booth J, Jaeger B. Association of sleep characteristics with nocturnal hypertension and nondipping blood pressure in the CARDIA study. J Am Heart Assoc. 2020;9:e015062.
https://doi.org/10.1161/jaha.119.015062
Kario K. Perfect 24-h management of hypertension: clinical relevance and perspectives. J Hum Hypertens. 2017;31:231–43.
https://doi.org/10.1038/jhh.2016.65
Häusler N, Marques-Vidal P, Haba-Rubio J. Association between actigraphy-based sleep duration variability and cardiovascular risk factors – results of a population-based study. Sleep Med. 2020;66:286–90.
https://doi.org/10.1016/j.sleep.2019.02.008
Booth J, Jaeger B, Huang L. Morning blood pressure surge and cardiovascular disease events and all-cause mortality in Blacks: the Jackson Heart Study. Hypertens. 2020;75:835–43.
https://doi.org/10.1161/hypertensionaha.119.14233
Hoshide S, Yano Y, Haimoto H. Morning and evening home blood pressure and risks of incident stroke and coronary artery disease in the Japanese general practice population: the Japan morning surge-home blood pressure study. Hypertens. 2016;68:54–61.
https://doi.org/10.1161/hypertensionaha.116.07201
Hermida R, Ayala D, Mojón A. Chronotherapy with nifedipine GITS in hypertensive patients: improved efficacy and safety with bedtime dosing. Am J Hypertens. 2008;21:948–54.
https://doi.org/10.1038/ajh.2008.216
Mayor SJB. Taking antihypertensives at bedtime nearly halves cardiovascular deaths when compared with morning dosing, study finds. BMJ. 2019;367:l6173.
https://doi.org/10.1136/bmj.l6173
Xie ZY, Zhang JH, Wang CY, Yan XW. Chronotherapy for morning blood pressure surge in hypertensive patients: a systematic review and meta-analysis, BMC Cardiovasc Disord. 2021;21:274
https://doi.org/10.1186/s12872-021-02081-8
Wang CX, Ye YQ, Liu CY, Zhou YM, Lv LS, Cheng CL, et al. Evening versus morning dosing regimen drug therapy for chronic kidney disease patients with hypertension in blood pressure patterns: a systematic review and meta-analysis. Intern Med J. 2017;47:900–6.
https://doi.org/10.1111/imj.13490
Schillaci G, Battista F, Settimi L, Luca S, Giacomo P. Antihypertensive drug treatment and circadian blood pressure rhythm: a review of the role of chronotherapy in hypertension. Curr Pharm Des. 2015;21:756–72
https://doi.org/10.2174/1381612820666141024130013
Smolensky MH, Hermida RC, Portaluppi F. Circadian mechanisms of 24-hour blood pressure regulation and patterning. Sleep Med Rev. 2017;33:4–16.
https://doi.org/10.1016/j.smrv.2016.02.003
Hermida RC, Mojón A, Smolensky MH, Fernández JR. Lowering nighttime blood pressure with bedtime dosing of antihypertensive medications: controversies in hypertension-pro side of the argument. Hypertens. 2021;78:879–93.
https://doi.org/10.1161/hypertensionaha.120.16500
Turgeon RD, Althouse AD, Cohen JB, Enache B, Hogenesch JB, Johansen ME, et al. Lowering nighttime blood pressure with bedtime dosing of antihypertensive medications: controversies in hypertension - con side of the argument. Hypertens. 2021;78:871–78.
https://doi.org/10.1161/hypertensionaha.121.16501
Brunström M, Kjeldsen SE, Kreutz R, Gjesdal K, Narkiewicz K, Burnier M, et al. Missing verification of source data in hypertension research: the HYGIA PROJECT in perspective. Hypertens. 2021;78:555–58.
https://doi.org/10.1161/hypertensionaha.121.17356
Burnier M, Kreutz R, Narkiewicz K, Kjeldsen S, Oparil S, Mancia G. Circadian variations in blood pressure and their implications for the administration of antihypertensive drugs: is dosing in the evening better than in the morning? J Hypertens. 2020;38:1396–406.
https://doi.org/10.1097/hjh.0000000000002532
Relates to: ‘bedtime hypertension treatment improves cardiovascular risk reduction: hygia chronotherapy trial’. Eur Heart J. 2020;41:1600–1600.
https://doi.org/10.1093/eurheartj/ehaa339
Lüscher TF, Fox K, Hamm C, Carter RE, Taddei S, Simoons M, et al. Scientific integrity: what a journal can and cannot do. Eur Heart J. 2020;41:4552–55.
https://doi.org/10.1093/eurheartj/ehaa963
Rorie DA, Rogers A, Mackenzie IS, Ford I, Webb DJ, Willams B, et al. Methods of a large prospective, randomized, open-label, blinded end-point study comparing morning versus evening dosing in hypertensive patients: the Treatment In Morning versus Evening (TIME) study. BMJ Open. 2016;6:e010313.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
